PRESS RELEASES

Biodesix Announces Data To Be Presented at AACR Annual Meeting 2017

New data on genomic tests and single-reaction, multiplexed genomic assays; evaluation of biological processes via mass spectrometry of human serum March 28, 2017, Boulder, Colorado…Biodesix, Inc. will present three posters summarizing new data from research evaluating...

Biodesix® and Progenetics Announce Distribution Agreement for Israel

March 9, 2017, Boulder, Colorado…Biodesix, Inc. (Boulder, CO, USA) and Progenetics LTD (Tel Aviv, Israel) announced today that they have entered into an international agreement where Progenetics will market and distribute kits for Biodesix’s GeneStrat® and...

Blood-Based Diagnostic Assay Measures Immunotherapy Biomarker PD-L1

Blood-Based Diagnostic Assay Measures Immunotherapy Biomarker PD-L1 ddPCR Assay Measures mRNA Expressions from Immune and Cancer Cell; Key Step In Development of Immunotherapy Test New data from Biodesix® evaluating an assay in development demonstrated the potential...

Clin-TOF Successfully Integrated into VeriStrat® Workflow

Clin-TOF Successfully Integrated into VeriStrat® Workflow

Study Results, Presented at MSACL, Advance Biodesix®/Bioyong Agreement Study results presented today demonstrate the feasibility of running the VeriStrat® test on Bioyong’s Clin-TOF platform, and provide a basis for validating and deploying a version of the VeriStrat®...

VIEW OUR BLOGS

READ

HOME     CONTACT     INVESTORS     TERMS & CONDITIONS     CAREERS     FAQ     SITE MAP     NEWS

ORDER A TEST KIT

CLICK HERE